be
BE
Belgium
en-BE
be_intm_classes
intm
Intermediary
en
en
For use by professional clients and/or equivalent investor types in your jurisdiction (not to be used with or passed on to retail clients).
Paternoster Square

Insights

Mythbusters: why the bad press around UK stocks doesn’t stack up

Jeremy Smith
Jeremy Smith
Head of UK Equities

Key Takeaways

  • There are many long-standing cliches associated with the UK stock market, several of which are detrimental to its reputation.
  • From valuations and the make-up of the index to perceived US superiority and mistaking the UK economy as a proxy for the equity market, many of these just don’t stand up to scrutiny.
  • We debunk six myths in detail and set out why the UK market is more than you might think.

It’s been a tough few years for UK equities – unloved, undervalued and often overlooked. Yet behind the doom-laden headlines lies a different story. Over the past 12 months the FTSE All-Share Index has quietly outperformed the S&P 500, the Nasdaq and even the much-hyped ‘Magnificent Seven’ US tech stocks1. Despite this, UK equities remain deeply discounted.

But making the case for UK equities is not about blind optimism – it’s actually about rebutting tired narratives, as well as exploring several developing tailwinds. So, let’s bust some myths …

Myth 1: Your capital is better off in US equities

You’d be forgiven for thinking US stocks are the only game in town. But over the past year, the FTSE benchmarks are actually outperforming US indices, with UK stalwart businesses like BT, Marks & Spencer and Imperial Brands2 outperforming, for example, Nvidia3.

Yes, the S&P 500 has delivered exceptional returns over the past decade, but it has also become problematically top-heavy. The Magnificent Seven now dominate global indices, with the US accounting for 72% of the MSCI World Index4. Indeed, in the past 10 years those seven stocks accounted for nearly 40% of overall S&P 500 gains in absolute terms. That’s a lot of exposure riding on just a few stocks. The UK overall is much less volatile. It saw no correction at the end of 2022, for example. This diversity is critical as macro volatility rises.

As Warren Buffett said, ‘Markets do badly when they forget companies grow earnings at 7% per annum … any performance better than 7% on a market level is just stealing future performance.’ With the US returning in excess of 12% for the past two years, perhaps it has been stealing future returns. The UK is
still playing the long game. 

Myth 2: London listings are inferior

Another common narrative is that serious global companies should list in New York. But the data doesn’t back that up. Over the past decade, only 20 UK companies have listed in the US and raised more than $100 million, compared to more than 200 in London. Of those 20, nine have already delisted and only four are trading above their IPO price5. Indeed, foreign issuers tend to underperform in the US in general: over the past five years, the average after-market US IPO price shows US companies down by 2% while non-US firms are down 31%. In contrast, London IPOs have seen similar or better medium-term returns, all with lower costs and less regulatory risk6.

So, although many firms are still eyeing New York, the reality is more nuanced than the headlines suggest.

Myth 3: Cheap means poor quality

We agree with Buffet on his maxim: ‘Price is what you pay, value is what you get.’7 Indeed, it is our firm belief that for stock markets as a whole, valuation is the clearest predictor of future investment performance. It is empirically rare for expensively valued markets to produce strong returns (Figure 1). There are numerous reasons behind this, but most obviously high valuations imply that investors are already well aware of, and perhaps fully invested in, the market. Yes, markets are driven in the long term by fundamentals such as earnings, cashflow and dividends, but in the shorter term more speculative investor flows often dominate share prices. If companies fail to live up to over-hyped expectations, their over-blown share prices can stagnate or even fall precipitously.

Figure 1: A clear pattern
S&P 500

Source IBES, LSEG Datastream, S&P Global, JP Morgan Asset Management, as of 31 March 2025. Dots represent monthly data points since 1988. Forward P/E ratio is price to 12-month forward earnings, calculated using IBES
earnings estimates.

The UK is cheap both historically and relative to its peers: currently, the FTSE All-Share Index is trading at around 13x prospective earnings, while the S&P 500 is trading at 23x, with Europe ex-UK and Japan at around 15x and 14x respectively8. Performance over 2024 is a perfect case study: UK stocks were too cheap, US ones too expensive. As those valuation differences adjusted, the UK outperformed. That valuation gap hasn’t fully closed – the opportunity remains.

Myth 4: The FTSE is full of dinosaur stocks

The FTSE’s reputation as a haven for oil majors, miners and banks misses the innovation that is happening across UK markets.

The UK is the second-largest venture capital (VC) market in the world after the US, and home to more unicorns9 than France and Germany combined10. From AI to biotech, SMID-cap companies like Alphawave, FD Technologies and Oxford Biomedica are driving innovation. Larger names like Experian, RELX and Pearson are also embracing tech transformation.

Reforms are also helping channel institutional capital into growth businesses to ensure these firms are given the time and support to develop as they should. The story of UK innovation is evolving.

Myth 5: The UK stock market is the same as the UK economy

There is a clear link in investors’ minds between a domestic economy and the success or failure of that country’s stock market. If an economy grows, surely the stock market will too? The US over the past century bears witness to that.

But there are also many reasons to believe that the performance of stock markets in general, and certainly many individual companies, can be unrelated to their domestic economies. Most obviously – and this is particularly true of the UK stock market – although companies may be listed domestically, many will earn substantial amounts of revenue overseas. Indeed, of the revenue generated by those companies that are part of the UK’s FTSE AllShare Index, latest figures show that just a quarter (25.3%) comes from the UK. This is almost exactly the same as the amount of revenue generated by those UK-listed companies in North America (25.6%). So, for the UK stock market index, revenues generated in the US are as important as those generated in the UK, and international revenue is almost three times more important than domestic revenue (Figure 2). Emphatically, the UK stock market is in no way a proxy for the UK economy.

Figure 2: An international flavour
FTSE all share revenue exposure

Source: FactSet Geographic Revenue Exposure (GeoRev) data, as of 31 March 2025

The point of labouring the lack of correlation between the UK stock market and economy is that there is plenty of anecdotal evidence that some investors and asset allocators have lost confidence in the UK economy and been throwing in the towel on UK stocks. And while the domestic economy has struggled, that
isn’t the case for UK equities.

Myth 6: UK dividends never recovered from Covid

The UK has a reputation for yield, but this took a hit during the Coronavirus pandemic as companies shored up their balance sheets. However, the yield from the UK stock market remains very favourable compared with other markets. In fact, with dividend yields around 4% (and names like Legal & General yielding between 7%-9%) and share buybacks rising considerably over the past few years, which reduces the number of shares outstanding and therefore increases earnings per share, UK-listed companies have returned more than £50 billion annually for the past three years11.

Far from being cut post-Covid, dividends have rebounded strongly. The UK’s capital-return culture is alive and well.

The bottom line

We believe there are multiple tailwinds forming behind UK equities:

  • The long-term structural selling by UK pension funds is ending.
  • With FTSE 350 companies still cheap relative to other markets, M&A activity is picking up as global buyers spot value.
  • Interest rate cuts remain on the table, with the Bank of England having more room to ease than the US Federal Reserve.
  • Political stability and fiscal focus on capital spending point to improving fundamentals.
  • With the rebalancing of the US exceptionalism trade, the UK stock market – with its capital-intensive bias and culture of delivering a major part of its return via good and growing income – will be a means of diversification

In addition, the valuation gap, international earnings base, and underappreciated innovation mean UK equities offer something rare in global markets today: quality and value. So, although the myths around the UK stock market are persistent, the numbers – and the performance – tell a new story. UK equities aren’t broken; they’re just misunderstood

Key topics

Subscribe to insights

Get the most out of your email by tailoring the types of insights and information you would like to receive from us.

Latest articles

From valuations and the make-up of the index to perceived US superiority and mistaking the UK economy as a proxy for the equity market, many of these just don’t stand up to scrutiny. We debunk six myths in detail.
The 30th April marked 100 days since President Trump took office, which is often a time to reflect on the achievements or otherwise of an incoming president.
With the global economy shifting, the case for European equities is stronger than it has been in years. We look at the opportunity, why stock selection will be key to success, and why quality will win out.
Key topics
Related topics

PDF

Mythbusters: why the bad press around UK stocks doesn’t stack up

1Bloomberg, as of April 2025
2Mention of specific stocks is not a recommendation to buy or sell
3Outperformance of Nvidia is over the previous 12 months as of 23 April 2025
4MSCI Inc, as of 31 March 2025
5Dealogic / LSE Workspace, March 2025
6Peel Hunt Annual Report 2024

7Forbes, The Important Differences Between Price And Value, January 2018
8Bloomberg Finance LP, current price/earnings ratio, as of 23 April 2025
9A privately held start-up company that has achieved a valuation of £1 billion or more
10 UK Finance, UK Public and Private Capital Markets, March 2025

Important information:

For use by professional clients and/or equivalent investor types in your jurisdiction (not to be used with or passed on to retail clients). For marketing purposes.

This document is intended for informational purposes only and should not be considered representative of any particular investment. This should not be considered an offer or solicitation to buy or sell any securities or other financial instruments, or to provide investment advice or services. Investing involves risk including the risk of loss of principal. Your capital is at risk. Market risk may affect a single issuer, sector of the economy, industry or the market as a whole. The value of investments is not guaranteed, and therefore an investor may not get back the amount invested. International investing involves certain risks and volatility due to potential political, economic or currency fluctuations and different financial and accounting standards. The securities included herein are for illustrative purposes only, subject to change and should not be construed as a recommendation to buy or sell. Securities discussed may or may not prove profitable. The views expressed are as of the date given, may change as market or other conditions change and may differ from views expressed by other Columbia Threadneedle Investments (Columbia Threadneedle) associates or affiliates. Actual investments or investment decisions made by Columbia Threadneedle and its affiliates, whether for its own account or on behalf of clients, may not necessarily reflect the views expressed. This information is not intended to provide investment advice and does not take into consideration individual investor circumstances. Investment decisions should always be made based on an investor’s specific financial needs, objectives, goals, time horizon and risk tolerance. Asset classes described may not be suitable for all investors. Past performance does not guarantee future results, and no forecast should be considered a guarantee either. Information and opinions provided by third parties have been obtained from sources believed to be reliable, but accuracy and completeness cannot be guaranteed. This document and its contents have not been reviewed by any regulatory authority.

In the UK: Issued by Threadneedle Asset Management Limited, No. 573204 and/or Columbia Threadneedle Management Limited, No. 517895, both registered in England and Wales and authorised and regulated in the UK by the Financial Conduct Authority.

In the EEA: Issued by Threadneedle Management Luxembourg S.A., registered with the Registre de Commerce et des Sociétés (Luxembourg), No. B 110242 and/or Columbia Threadneedle Netherlands B.V., regulated by the Dutch Authority for the Financial Markets (AFM), registered No. 08068841.

This document may be made available to you by an affiliated company which is part of the Columbia Threadneedle Investments group of companies: Columbia Threadneedle Management Limited in the UK; Columbia Threadneedle Netherlands B.V., regulated by the Dutch Authority for the Financial Markets (AFM), registered No. 08068841.

Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies. © Columbia Threadneedle. All rights reserved.

Related Insights

1 May 2025

Francis Ellison

Client Portfolio Manager

Frederic Jeanmaire

Portfolio Manager

Why the time is ripe for Europe

With the global economy shifting, the case for European equities is stronger than it has been in years. We look at the opportunity, why stock selection will be key to success, and why quality will win out.
4 April 2025

David Egan

Senior Research Analyst

Dick Manuel

Senior Analyst, Equity Research

How artificial intelligence is reshaping financial services

AI is helping enhance efficiency, reduce costs and improve decision-making.
19 March 2025

William Davies

Global Chief Investment Officer

Navigating market volatility amid US tariffs and policy uncertainty

Amid uncertainty in equities and credit markets, we remain focused on long-term investment fundamentals and building portfolios to weather the storm and deliver for clients.
6 May 2025

Anthony Willis

Senior Economist

Market Perspectives: What do the first 100 days of Trump mean for the next 1,361?

The 30th April marked 100 days since President Trump took office, which is often a time to reflect on the achievements or otherwise of an incoming president.
1 May 2025

Francis Ellison

Client Portfolio Manager

Frederic Jeanmaire

Portfolio Manager

Why the time is ripe for Europe

With the global economy shifting, the case for European equities is stronger than it has been in years. We look at the opportunity, why stock selection will be key to success, and why quality will win out.
28 April 2025

Fixed Income Desk

In Credit - Weekly Snapshot

In Credit Weekly Snapshot – April 2025

Our fixed income team provide their weekly snapshot of market events.

Important information:

For use by professional clients and/or equivalent investor types in your jurisdiction (not to be used with or passed on to retail clients). For marketing purposes.

This document is intended for informational purposes only and should not be considered representative of any particular investment. This should not be considered an offer or solicitation to buy or sell any securities or other financial instruments, or to provide investment advice or services. Investing involves risk including the risk of loss of principal. Your capital is at risk. Market risk may affect a single issuer, sector of the economy, industry or the market as a whole. The value of investments is not guaranteed, and therefore an investor may not get back the amount invested. International investing involves certain risks and volatility due to potential political, economic or currency fluctuations and different financial and accounting standards. The securities included herein are for illustrative purposes only, subject to change and should not be construed as a recommendation to buy or sell. Securities discussed may or may not prove profitable. The views expressed are as of the date given, may change as market or other conditions change and may differ from views expressed by other Columbia Threadneedle Investments (Columbia Threadneedle) associates or affiliates. Actual investments or investment decisions made by Columbia Threadneedle and its affiliates, whether for its own account or on behalf of clients, may not necessarily reflect the views expressed. This information is not intended to provide investment advice and does not take into consideration individual investor circumstances. Investment decisions should always be made based on an investor’s specific financial needs, objectives, goals, time horizon and risk tolerance. Asset classes described may not be suitable for all investors. Past performance does not guarantee future results, and no forecast should be considered a guarantee either. Information and opinions provided by third parties have been obtained from sources believed to be reliable, but accuracy and completeness cannot be guaranteed. This document and its contents have not been reviewed by any regulatory authority.

In the UK: Issued by Threadneedle Asset Management Limited, No. 573204 and/or Columbia Threadneedle Management Limited, No. 517895, both registered in England and Wales and authorised and regulated in the UK by the Financial Conduct Authority.

In the EEA: Issued by Threadneedle Management Luxembourg S.A., registered with the Registre de Commerce et des Sociétés (Luxembourg), No. B 110242 and/or Columbia Threadneedle Netherlands B.V., regulated by the Dutch Authority for the Financial Markets (AFM), registered No. 08068841.

This document may be made available to you by an affiliated company which is part of the Columbia Threadneedle Investments group of companies: Columbia Threadneedle Management Limited in the UK; Columbia Threadneedle Netherlands B.V., regulated by the Dutch Authority for the Financial Markets (AFM), registered No. 08068841.

Columbia Threadneedle Investments is the global brand name of the Columbia and Threadneedle group of companies. © Columbia Threadneedle. All rights reserved.

Thank you. You can now visit your preference centre to choose which insights you would like to receive by email.

To view and control which insights you receive from us by email, please visit your preference centre.

Woman listens to music through headphones
Play Video

CT Property Trust- Fund Manager Update

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium